|
|
|
The RESPImmun Young Faculty
List of publications:
10 most significant publications:
- Alkan HF, Vesely PW, Hackl H, Foßelteder J, Schmidt DR, Vander Heiden MG, Pichler M, Hoefler G, Bogner-Strauss JG:
Deficiency of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis.
Cancer Metab, 2020; 8(1):26.
- :
.
JRNL, 0000; 000(0):000–000.
- :
.
JRNL, 0000; 000(0):000–000.
- :
.
JRNL, 0000; 000(0):000–000.
- :
.
JRNL, 0000; 000(0):000–000.
- :
.
JRNL, 0000; 000(0):000–000.
- :
.
JRNL, 0000; 000(0):000–000.
- :
.
JRNL, 0000; 000(0):000–000.
- :
.
JRNL, 0000; 000(0):000–000.
- Huang J, Li L, Lian J, Schauer S, Vesely PW, Kratky D, Hoefler G, Lehner R:
Tumor-Induced Hyperlipidemia Contributes to Tumor Growth.
Cell Rep, 2016; 15(2):336–348.
- Das SK, Stadelmeyer E, Schauer S, Schwarz A, Strohmaier H, Claudel T, Zechner R, Hoefler G, Vesely PW:
Micro RNA-124a regulates lipolysis via adipose triglyceride lipase and comparative gene identification 58.
Int J Mol Sci, 2015; 16(4):8555–8568.
- Al-Zoughbi W, Pichler M, Gorkiewicz G, Guertl-Lackner B, Haybaeck J, Jahn SW, Lackner C, Liegl-Atzwanger B, Popper H, Schauer S, Nusshold E, Kindt AS, Trajanoski Z, Speicher MR, Haemmerle G, Zimmermann R, Zechner R, Vesely PW, Hoefler G:
Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia.
Oncotarget, 2016; 7(23):33832–33840.
- Tamilarasan KP, Temmel H, Das SK, Al Zoughbi W, Schauer S, Vesely PW, Hoefler G:
Skeletal muscle damage and impaired regeneration due to LPL-mediated lipotoxicity.
Cell Death Diss, 2012; 3:e354.
- Laimer D*, Dolznig H*, Kollmann K*, Vesely PW*, Schlederer M, Merkel O, Schiefer AI, Hassler MR, Heider S,
Amenitsch L, Thallinger C, Staber PB, Simonitsch-Klupp I, Artaker M, Lagger S, Turner SD, Pileri S,
Piccaluga PP, Valent P, Messana K, Landra I, Weichhart T, Knapp S, Shehata M, Todaro M, Sexl V,
Höfler G, Piva R, Medico E, Ruggeri BA, Cheng M, Eferl R, Egger G, Penninger JM, Jaeger U,
Moriggl R, Inghirami G, Kenner L:
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.
Nat Med, 2012; 18(11):1699–1704.
(equal contribution)
- Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, Gorkiewicz G, Tamilarasan KP, Kumari P, Trauner M, Zimmermann R, Vesely P, Haemmerle G, Zechner R, Hoefler G:
Adipose triglyceride lipase contributes to cancer-associated cachexia.
Science, 2011; 333(6039):233–238.
- Pflegerl P, Vesely P, Hantusch B, Schlederer M, Zenz R, Janig E, Steiner G, Meixner A, Petzelbauer P, Wolf P, Soleiman A, Egger G, Moriggl R, Kishimoto T, Wagner EF, Kenner L:
Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling.
Proc Natl Acad Sci USA, 2009; 106(48):20423–20428.
- Vesely PW*, Staber PB*, Hoefler G, Kenner L:
Translational regulation mechanisms of AP-1 proteins.
Mutat Res, 2009; 682(1):7–12.
(equal contribution)
- Staber PB*, Vesely P*, Haq N, Ott RG, Funato K, Bambach I, Fuchs C, Schauer S, Linkesch W, Hrzenjak A, Dirks WG, Sexl V, Bergler H, Kadin ME, Sternberg DW, Kenner L, Hoefler G:
The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.
Blood, 2007; 110(9):3374–3383.
|